324 related articles for article (PubMed ID: 16337611)
1. Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling.
Burg D; Riepsaame J; Pont C; Mulder G; van de Water B
Biochem Pharmacol; 2006 Jan; 71(3):268-77. PubMed ID: 16337611
[TBL] [Abstract][Full Text] [Related]
2. 4-Aryl-1,3,2-oxathiazolylium-5-olate: a novel GST inhibitor to release JNK and activate c-Jun for cancer therapy.
Cui H; Shen J; Lu D; Zhang T; Zhang W; Sun D; Wang PG
Cancer Chemother Pharmacol; 2008 Aug; 62(3):509-15. PubMed ID: 18008069
[TBL] [Abstract][Full Text] [Related]
3. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate.
Cacciatore I; Caccuri AM; Cocco A; De Maria F; Di Stefano A; Luisi G; Pinnen F; Ricci G; Sozio P; Turella P
Amino Acids; 2005 Nov; 29(3):255-61. PubMed ID: 16082503
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis.
Yu ST; Chen TM; Chern JW; Tseng SY; Chen YH
Anticancer Drugs; 2009 Jun; 20(5):382-8. PubMed ID: 19318911
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways.
Ruscoe JE; Rosario LA; Wang T; Gaté L; Arifoglu P; Wolf CR; Henderson CJ; Ronai Z; Tew KD
J Pharmacol Exp Ther; 2001 Jul; 298(1):339-45. PubMed ID: 11408560
[TBL] [Abstract][Full Text] [Related]
6. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
Adler V; Pincus MR
Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
[TBL] [Abstract][Full Text] [Related]
7. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
8. Importance of glutathione and associated enzymes in drug response.
Shen H; Kauvar L; Tew KD
Oncol Res; 1997; 9(6-7):295-302. PubMed ID: 9406235
[TBL] [Abstract][Full Text] [Related]
9. Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis.
Asakura T; Sasagawa A; Takeuchi H; Shibata S; Marushima H; Mamori S; Ohkawa K
Apoptosis; 2007 Jul; 12(7):1269-80. PubMed ID: 17431793
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase pi regulates UV-induced JNK signaling in SH-SY5Y neuroblastoma cells.
Castro-Caldas M; Milagre I; Rodrigues E; Gama MJ
Neurosci Lett; 2009 Feb; 451(3):241-5. PubMed ID: 19159663
[TBL] [Abstract][Full Text] [Related]
11. Peptidomimetic glutathione analogues as novel gammaGT stable GST inhibitors.
Burg D; Filippov DV; Hermanns R; van der Marel GA; van Boom JH; Mulder GJ
Bioorg Med Chem; 2002 Jan; 10(1):195-205. PubMed ID: 11738622
[TBL] [Abstract][Full Text] [Related]
12. Proapoptotic activity of new glutathione S-transferase inhibitors.
Turella P; Cerella C; Filomeni G; Bullo A; De Maria F; Ghibelli L; Ciriolo MR; Cianfriglia M; Mattei M; Federici G; Ricci G; Caccuri AM
Cancer Res; 2005 May; 65(9):3751-61. PubMed ID: 15867371
[TBL] [Abstract][Full Text] [Related]
13. [Anti-cancer drug resistance and glutathione S-transferases].
Sato K; Tsuchida S; Tamai K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):592-8. PubMed ID: 2650631
[TBL] [Abstract][Full Text] [Related]
14. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
15. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
[TBL] [Abstract][Full Text] [Related]
16. Nuclear glutathione S-transferase pi prevents apoptosis by reducing the oxidative stress-induced formation of exocyclic DNA products.
Kamada K; Goto S; Okunaga T; Ihara Y; Tsuji K; Kawai Y; Uchida K; Osawa T; Matsuo T; Nagata I; Kondo T
Free Radic Biol Med; 2004 Dec; 37(11):1875-84. PubMed ID: 15528046
[TBL] [Abstract][Full Text] [Related]
17. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
18. Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors.
Ciaccio PJ; Shen H; Jaiswal AK; Lyttle MH; Tew KD
Mol Pharmacol; 1995 Oct; 48(4):639-47. PubMed ID: 7476889
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutathione conjugation by glutathione analogues in the perfused rat liver. Effect of esterification on the potency of gamma-L-glutamyl-alpha-(D-2-aminoadipyl)-N-2-heptylamine.
Ouwerkerk-Mahadevan S; Tirona RG; Ripping RA; Ploemen JH; van Bladeren PJ; Pang KS; van Boom JH; Mulder GJ
Drug Metab Dispos; 1997 Oct; 25(10):1137-43. PubMed ID: 9321516
[TBL] [Abstract][Full Text] [Related]
20. The synthesis of ethacrynic acid thiazole derivatives as glutathione S-transferase pi inhibitors.
Li T; Liu G; Li H; Yang X; Jing Y; Zhao G
Bioorg Med Chem; 2012 Apr; 20(7):2316-22. PubMed ID: 22370342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
